DEUTSCHE BANK AG\ - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$122,000
-10.9%
94,911
-12.0%
0.00%
Q4 2021$137,000
-46.7%
107,860
-8.7%
0.00%
Q3 2021$257,000
-40.8%
118,140
+1.8%
0.00%
Q2 2021$434,000
+22.9%
116,073
+7.0%
0.00%
Q1 2021$353,000
-9.0%
108,455
-4.7%
0.00%
Q4 2020$388,000
-11.0%
113,782
+6.6%
0.00%
Q3 2020$436,000
-73.9%
106,756
-78.4%
0.00%
-100.0%
Q2 2020$1,669,000
+52.0%
494,031
+4.8%
0.00%0.0%
Q1 2020$1,098,000
+84.5%
471,329
+187.4%
0.00%
Q4 2019$595,000
-69.2%
164,004
-29.6%
0.00%
-100.0%
Q3 2019$1,931,000
-72.6%
232,944
-71.5%
0.00%
-75.0%
Q2 2019$7,046,000
+52.9%
818,530
+89.8%
0.00%
+33.3%
Q1 2019$4,608,000
+29.0%
431,194
+5.6%
0.00%0.0%
Q4 2018$3,572,000
-81.5%
408,433
-64.4%
0.00%
-50.0%
Q3 2018$19,288,000
+11.0%
1,148,237
+38.5%
0.01%
+20.0%
Q2 2018$17,377,000
+48.0%
829,086
+13.6%
0.01%
-16.7%
Q1 2018$11,739,000
+48.3%
729,690
+74.7%
0.01%
+20.0%
Q4 2017$7,915,000
-38.2%
417,765
-54.1%
0.01%
-44.4%
Q3 2017$12,808,000
+127.5%
910,369
+20.5%
0.01%
+125.0%
Q2 2017$5,629,000
+59.3%
755,723
+39.0%
0.00%
+33.3%
Q1 2017$3,534,000
-35.1%
543,826
-55.8%
0.00%
-25.0%
Q4 2016$5,449,000
-30.2%
1,230,669
-26.4%
0.00%
-33.3%
Q3 2016$7,807,000
-31.1%
1,672,102
-3.0%
0.01%
-25.0%
Q2 2016$11,324,000
+30.4%
1,723,971
+26.2%
0.01%
+14.3%
Q1 2016$8,683,000
+8.1%
1,365,667
+2.5%
0.01%
+16.7%
Q4 2015$8,030,000
+34.9%
1,332,044
+33.8%
0.01%
+20.0%
Q3 2015$5,954,000
+43.5%
995,890
+64.1%
0.01%
+66.7%
Q2 2015$4,150,000
+36.3%
606,931
+21.0%
0.00%
+50.0%
Q1 2015$3,045,000
+56.2%
501,798
+78.3%
0.00%
+100.0%
Q4 2014$1,949,000
-9.3%
281,481
+6.5%
0.00%0.0%
Q3 2014$2,150,000
-27.2%
264,398
-27.3%
0.00%
-50.0%
Q2 2014$2,954,000
+33.3%
363,458
+28.6%
0.00%0.0%
Q1 2014$2,216,000
+1.9%
282,727
+15.0%
0.00%0.0%
Q4 2013$2,174,000
+89.0%
245,839
+78.9%
0.00%
+100.0%
Q3 2013$1,150,000137,4280.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
Crestline Management, LP 65,362$51,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders